Class 4 drug alert – Caution in Use – Zapain tablets 30mg/500mg (codeine phosphate /paracetamol)

14 Jan 2020

A Class 4 medicines defect information alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for Zapain tablets 30mg/500mg (codeine phosphate/paracetamol)

Ref: EL (20)A/01

14 January 2020

Zapain tablets 30mg/500mg (Codeine Phosphate/Paracetamol)

(Manufactured by Advanz Pharma)

PL 12762/0034

A Class 4 medicines defect information alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for specific batches of Zapain tablets 30mg/500mg (codeine phosphate/paracetamol). Advanz Pharma has informed the MHRA of a discrepancy on the packaging of affected batches containing tablets that have been incorrectly labelled as “capsules”.

Affected batches together with further information can be found on the MHRA section on the GOV.UK website.

Produced by the NPA Pharmacy Services team January 2020.